Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Citi
Express Scripts
Boehringer Ingelheim
Accenture
UBS
Chinese Patent Office
Fish and Richardson
McKesson

Generated: February 20, 2018

DrugPatentWatch Database Preview

OVULEN Drug Profile

« Back to Dashboard

When do Ovulen patents expire, and when can generic versions of Ovulen launch?

Ovulen is a drug marketed by Gd Searle Llc and is included in two NDAs.

The generic ingredient in OVULEN is ethynodiol diacetate; mestranol. There are four drug master file entries for this compound. Additional details are available on the ethynodiol diacetate; mestranol profile page.
Summary for OVULEN
Drug patent expirations by year for OVULEN

US Patents and Regulatory Information for OVULEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gd Searle Llc OVULEN ethynodiol diacetate; mestranol TABLET;ORAL-20 016029-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Gd Searle Llc OVULEN-21 ethynodiol diacetate; mestranol TABLET;ORAL-21 016029-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Gd Searle Llc OVULEN-28 ethynodiol diacetate; mestranol TABLET;ORAL-28 016705-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Covington
Accenture
Cipla
Baxter
Teva
Healthtrust
Citi
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot